Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

The Myth of Average: Why Individual Patient Differences Matter

Within today’s health care environment, so much of the research that is conducted and the treatment decisions that are being made are based on assumptions of an “average” patient. But as we learn more about treatments and optimal care, it’s very clear that most patients are not “average” at all.

Our bodies respond in different ways to the same treatment because of a wide variety of factors, such as racial and ethnic backgrounds, age, genetics, chronic conditions, gender, environment, and even personal preferences when it comes to health treatments. A one-size-fits-all approach to health care will not provide patients with the optimal care they need and deserve.

In this publication, “The Myth of Average: Why Individual Patient Differences Matter,” the National Pharmaceutical Council explores the reasons behind differences in treatment effects and offers a checklist that patients can use when talking to their health care providers.

Among the multiple issues covered, the booklet also includes:

  • information on the science behind patient differences,
  • the importance of comparative effectiveness research that takes these differences into consideration, and
  • the challenges involved in providing health coverage –and access to a range of different treatments—for patients who are not at all “average.”

Press Release

Michael Ciarametaro Joins National Pharmaceutical Council as Director of Research

WASHINGTON, DC (July 31, 2014)—The National Pharmaceutical Council (NPC) today announced that Michael Ciarametaro has joined the health policy...
Press Release

NPC Study Outlines When & How Health Decision-Makers Should Consider Individual Patient Differences

Washington, DC (July 29, 2014)—New research led by the National Pharmaceutical Council (NPC) can assist health care stakeholders to understand when...
Newsletter Volume

E.V.I.dently July 2014

NPC MessageWhen & How Health Decision-Makers Should Consider Individual Patient DifferencesBy Jennifer S. Graff, PharmD, NPC Director of...
YouTube Videos

Consumer-Directed Health Plans

A unique survey of large employers sheds light on the strategies and best practices that they follow when designing and implementing consumer-...
Press Release

Michael Ciarametaro Joins National Pharmaceutical Council as Director of Research

WASHINGTON, DC (July 31, 2014)—The National Pharmaceutical Council (NPC) today announced that Michael Ciarametaro has joined the health policy...
Press Release

NPC Study Outlines When & How Health Decision-Makers Should Consider Individual Patient Differences

Washington, DC (July 29, 2014)—New research led by the National Pharmaceutical Council (NPC) can assist health care stakeholders to understand when...
Press Release

NPC, UMD Study: Factors That Cause Different Treatment Responses Are Not Well Understood or Studied

Washington, DC, November 4, 2013—Although researchers and health care providers widely recognize that individuals with stage IV prostate cancer react...
Press Release

National Pharmaceutical Council Comments on PCORI Approval of Research Methodology Standards

Washington, DC (November 19, 2012)—The National Pharmaceutical Council (NPC) today commented on the Patient-Centered Outcomes Research Institute’s (...
Commentary and Testimony Page

NPC Comments on CMS' Proposed Changes to Protected Classes

March 7, 2014Marilyn B. TavennerAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of Health and Human Services200 Independence...
Commentary and Testimony Page

The Risks of Standardized Health Care

Think about the last time you visited a medical office. Even at a specialist’s office, chances are that each person waiting for his or her name to be...
Commentary and Testimony Page

Questions Abound on the Adoption of Evidence

Medical decision making should rely on evidence (when available) to ensure that treatments are appropriate and effective for patients. Given the...
Commentary and Testimony Page

Health Affairs CER Briefing Highlights Key Issues

Just one week after the appointment of the board of governors for the new comparative effectiveness research (CER) body, the Patient-Centered...
YouTube Videos

Consumer-Directed Health Plans

A unique survey of large employers sheds light on the strategies and best practices that they follow when designing and implementing consumer-...
YouTube Videos

Engaging Consumers in Today's Changing Health Care Payment and Delivery Environment

The current health care delivery system is evolving from a fee-for-service system to one that is performance-based. How does this shift impact...
YouTube Videos

Using Distributed Data Networks to Understand Heterogeneity in Real-World Data

Kimberly Westrich, director of health services research at the National Pharmaceutical Council, explains how large observational datasets like...
YouTube Videos

Taking Patient Variations Into Account

Dr. Lisa Egbuonu-Davis, founder of ROI Squared, explains that data is generally designed toward looking at the mean differences instead of the...
Blog Post

#TBT: Consumer-Directed Health Plans & Employers’ Decision-Making

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

NPC to Discuss Role of Pharmaceuticals, Applying Real-World Evidence at ISPOR Annual Meeting

Planning to attend the International Society for Pharmacoeconomics and Outcomes Research’s (ISPOR) 19th Annual International Meeting in Montreal May...
Blog Post

The Good, the Bad and the Different

The story line in any spaghetti western generally follows a predictable plot. There are a few shoot outs between the good guys and the bad guys, some...
Blog Post

#TBT: Enrollment Deadline & the Role of Rx in Health Exchanges

As part of our “Throwback Thursday” blog series, we’re taking a look at a research topic that’s currently in the news and tagging it with...

Research

The Emerging Relevance of Heterogeneity of Treatment Effect in Clinical Care: A Study Using Stage IV Prostate Cancer as a Model

Although researchers and health care providers widely recognize that individuals with stage IV...
  •  
  • 1 of 33
  • >

Commentary & Testimony